Bone density can be precisely determined using a method called bone densitometry and is used to evaluate bone loss. It is a form of cutting-edge X-ray technology that can assess a person’s risk of fractures and detect osteopenia or osteoporosis. A bone densitometer can also be used to visualize the structure of the bone and quantify calcium and other minerals in the bone section.
The market worth of bone densitometer in 2021 was USD 312.33 million, and it will be worth USD 448.79 million by 2030, growing at a 4.11% CAGR during the forecast period.
An increase in the prevalence of osteoporosis and osteopenia illness in women following menopause will fuel the expansion of the bone densitometer market. Moreover, the global bone densitometer market will rise as a result of growing awareness of osteoporosis worldwide and the provision of education and support services by numerous governments and non-profit organizations.
The increasing incidence of osteoporosis is the main factor fuelling the market’s expansion. The older population is more vulnerable to osteoporosis and fractures, fuelling market expansion. Rapid increases in the burden of osteoporosis are caused by urbanization and aging populations, which are boosting market growth. Furthermore, the market is expanding as a result of rising technical improvements on a global scale. In addition, a significant factor driving the market is the prevalence of osteoporosis in menopausal women.
The market’s expansion is being hampered by lower awareness, more expensive technology, and a shortage of medical personnel, particularly in developing and underdeveloped economies.
The market for bone densitometers will have tremendous room to grow as a result of expanding economies and peoples’ constantly changing lifestyles. The bone densitometer market will generate more than $20 million in sales in China by 2027 and more than $17 million in India.
Future market demand will also be driven by emerging market trends, many osteoporosis awareness campaigns run by NGOs, and numerous journals of clinical densitometry (j clin densitometry) produced by numerous publishers globally.
By Type, Because of the extensive usage of densitometers based on this technique, axial bone densitometry held the most significant market share for bone densitometer devices. Additionally, given the high frequency of orthopedic patients, the rising adoption rate can be attributed to axial bone densitometers meeting several clinical requirements.
By technology, Over half of the market for bone densitometers was ruled by the Dual Energy X-Ray Absorptiometry (DXA Or Dexa) industry in 2020. It will expand at a CAGR of 4.3% between 2020 and 2030, increasing the incidence of orthopedic ailment treatments worldwide. The method of axial bone densitometry that is utilized the most is DEXA bone density.
By end-user, the hospital segment will grow at a rapid rate. However, due to the surge in orthopedic patients, the Diagnostic Centers industry is anticipated to grow quickly. The clinic segment will expand at a 4.3% CAGR during 2020-2030 due to the ongoing increase in instrument prices.
North America was the largest market for bone densitometers. As a result of numerous cooperation initiatives undertaken by well-known companies in this area to improve their R&D capabilities and uphold high medical standards, the demand will rise throughout the region. According to the National Osteoporosis Foundation, the risk is increased for the almost 10 million Americans who have osteoporosis and the 44 million Americans with insufficient bone density. 54 million adults over the age of 50, or half of all adults, are in danger of breaking a bone and should be concerned about their bone health.
However, due to rising healthcare spending and R&D for new product releases in the region, Asia-Pacific will grow at the quickest rate of 5.3% from 2020 to 2030.
- GE Healthcare
- Nanjing Kejin Industrial Co. Ltd
- Oscare Medical Oy
- Trivitron Healthcare
- Hologic Inc.
- OSI Systems Inc.
- Echolight S.P.A
- BeamMed Ltd.
- Diagnostic Medical Systems Group
- Swissray Global Healthcare Holding Ltd.
- YOZMA BMTech Co. Ltd.
- Scanflex Healthcare AB
- CyberLogic Inc.
- Eurotec Systems S.r.l
- Medonica Co. Ltd.
- Anjue Medical Equipment
- Ampall Co. Ltd.
The market worth of bone densitometer in 2021 was USD 312.33 million, and it will be worth USD 448.79 million by 2030, growing at a 4.11% CAGR during the forecast period. One of the main drivers propelling the market is the rise in the population of older individuals, particularly susceptible to bone-related diseases, including osteoporosis and arthritis.